Lilly says Mounjaro and Zepbound contributed to big revenue boost
Eli Lilly & Co. said its Type-2 Diabetes drug Mounjaro and weight-loss/diabetes medicine Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion.
Making Frugal Fun on MSN20h
How to Save Money on Groceries (without coupons)
Grocery prices seem like they keep going UP! So should you start your extreme couponing journey…or are there ways to save ...
New rules will make it harder for those with eating disorders to buy weight loss jabs
Changes are coming into force which will make it harder to buy weight loss medication, such as Wegovy and Mounjaro, online – ...